Comparison of Two Contrast Agents in the Evaluation of Kidney and Adrenal Findings in MRI
Descrizione riassuntiva dello studio
When unclear masses are discovered in an organ during an examination, these so-called incidental findings must be further investigated. This is sometimes done with an additional, targeted examination of the affected organ. In this case, masses found in the kidneys or adrenal glands are further examined using MRI. This examination in our clinic is supported by a contrast agent containing the active ingredient Gadobutrol. In our study, we aim to quantify how effective a new contrast agent called Gadopiclenol is. We do not yet use this new contrast agent in our routine, but it is already being used in the USA and in other countries in Europe. There is already research on humans regarding this contrast agent, and previous studies on humans as well as clinical applications have shown that it is safe and effective for diagnostics. Therefore, in this study, we investigate to what extent the new contrast agent is comparable to the old one, which could not be determined from the already existing qualitative assessment.
(BASEC)
Intervento studiato
In this study, the contrast agent Gadopiclenol is investigated in the evaluation of incidental findings in the kidneys and adrenal glands using MRI.
(BASEC)
Malattie studiate
Investigation of a new contrast agent in the evaluation of kidney and adrenal findings in MRI
(BASEC)
Patients who require an MRI evaluation of kidney or adrenal findings, are older than 17 years, and are compatible with MRI. (BASEC)
Criteri di esclusione
Patients who have a contraindication for MRI, such as certain implants, or suffer from severe renal impairment, as well as pregnant and breastfeeding women will be excluded from the study. (BASEC)
Luogo dello studio
Berna
(BASEC)
Sponsor
Inselspital Bern
(BASEC)
Contatto per ulteriori informazioni sullo studio
Persona di contatto in Svizzera
Prof. Dr. med. Andreas Christe
+41 31 632 19 65
andreas.christe@clutterinsel.chDepartment of Diagnostic, Interventional and Pediatric Radiology Inselspital, Bern University Hospital, Bern, Switzerland Rosenbühlgasse 27 CH-3010 Bern
(BASEC)
Informazioni scientifiche
non disponibile
Nome del comitato etico approvante (per studi multicentrici solo il comitato principale)
Commissione d'etica Berna
(BASEC)
Data di approvazione del comitato etico
16.06.2025
(BASEC)
ID di studio ICTRP
non disponibile
Titolo ufficiale (approvato dal comitato etico)
Randomized, single-blind, monocentric, non-inferiority trial of gadopiclenol (Vueway®) contrast agent performance vs. gadobutrol (Gadovist®) in the workup of incidental renal and adrenal findings (BASEC)
Titolo accademico
non disponibile
Titolo pubblico
non disponibile
Malattie studiate
non disponibile
Intervento studiato
non disponibile
Tipo di studio
non disponibile
Disegno dello studio
non disponibile
Criteri di inclusione/esclusione
non disponibile
non disponibile
Endpoint primari e secondari
non disponibile
non disponibile
Data di registrazione
non disponibile
Inclusione del primo partecipante
non disponibile
Sponsor secondari
non disponibile
Contatti aggiuntivi
non disponibile
ID secondari
non disponibile
Risultati-Dati individuali dei partecipanti
non disponibile
Ulteriori informazioni sullo studio
non disponibile
Risultati dello studio
Riepilogo dei risultati
non disponibile
Link ai risultati nel registro primario
non disponibile